Chief Executive Officer
Siemens Healthcare Diagnostics
On May 1, 2010, Michael Reitermann assumed the role of CEO, Siemens Healthcare Diagnostics Inc. In this position, Mr. Reitermann is responsible for the Siemens Healthcare Diagnostics division. Mr. Reitermann is based in Tarrytown, NY.
Mr. Reitermann’s passion for science and technology has driven his extensive career with Siemens. In his previous role Mr. Reitermann was responsible for the U.S. imaging organization. Before that assignment, he served as CEO of the Siemens Molecular Imaging Business Unit. Mr. Reitermann was responsible for the establishment and implementation of the Molecular Imaging’s business objectives around the world, as well as the Business Unit’s overall financial performance. During his tenure, Siemens launched the Symbia, Biograph Truepoint and Biograph mCT product lines.
Reitermann has enjoyed a long career with Siemens, including serving as vice president for sales, marketing and innovation of the Siemens Angiography and X-ray Division (AX). In this position, Reitermann was responsible for product definition and worldwide marketing and promotion of Siemens AX products, including the successful AXIOM product line. From 1996 to 1998, he also served as a partner in Siemens Management Consulting, conducting consulting projects in the areas of benchmarking, strategy and productivity. Prior to 1996, Reitermann worked as a consultant, then a senior project manager at the corporate strategies division of Siemens Corporate Planning and Development.
Educated at Hans-Grueninger-Gymnasium in Markgroeningen, Germany, Reitermann received a graduate degree in industrial engineering from the University of Karlsruhe, Germany, and a master’s of business administration from the University of British Columbia, Canada.